VP1-001

N/A

Report date: 2024/10/17 17:05:44
NME

Base Information

Drug NameVP1-001
Drug Alias Namecompound 29
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid inhibitorsCrystallin Alpha B binders
TargetsAmyloidAlpha-Crystallin B Chain
Therapy Area/IndicationsPresbyopiaCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of MichiganUc San FranciscoUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUc San FranciscoViewpoint Therapeutics IncUniversity Of Michigan +[4] 
Active IndicationsN/A
Inactive IndicationsPresbyopiaCataract

Other Information

ATC CodeN/A
Related LinksN/A